702 Phase 1 study of DLL3-directed chimeric antigen receptor T-cells in subjects with extensive stage small cell lung cancer

• Zhonglin Hao,
• Alberto Chiappori,
• Adam Schoenfeld,
• Paul Schwarzenberger,
• Jacob Sands,
• Lida Pacaud,
• Christopher delCorral,
• Dong Geng,
• Zhong Yun,
• Chaun Wang,
• Gianni Amato,
• Sahista Vahora

Affiliations

Zhonglin Hao

Aff1 0000 0001 2284 9329grid.410427.4Georgia Cancer Center at Augusta University Augusta GA USA

Alberto Chiappori

1Moffitt Cancer Center, Tampa, FL, USA

Adam Schoenfeld

Department of Medicine, Weill Cornell Medical College, New York, NY, USA

Paul Schwarzenberger

9Merck and Co., Inc., Kenilworth, NJ, USA

Jacob Sands

Dana-Farber Cancer Institute, Boston, Massachusetts, USA

Lida Pacaud

6 Legend Biotech USA Inc, Piscataway, New Jersey, USA

Christopher delCorral

3Legend Biotech, Somerset, NJ, USA

Dong Geng

3Legend Biotech, Somerset, NJ, USA

Zhong Yun

3Legend Biotech, Somerset, NJ, USA

Chaun Wang

3Legend Biotech, Somerset, NJ, USA

Gianni Amato

3Legend Biotech, Somerset, NJ, USA

Sahista Vahora

3Legend Biotech, Somerset, NJ, USA